Application of enhanced recovery after surgery in lumbar fusion surgery

Zhiwei YANG,Xiaojuan SHI,Li GUO,Chen WANG,Zhengxu YE,Zhe WANG,Xueyu HU,Zhuojing LUO
DOI: https://doi.org/10.3969/j.issn.1674-8573.2017.02.011
2017-01-01
Abstract:Objective To study the effect of enhanced recovery after surgery (ERAS) on patients with lumbar fusion surgery in spine surgery. Methods There were 236 patients receiving lumbar fusion surgery whose fusion segments were no more than 3 from January 2015 to August 2015. The patients were divided into control group (117 cases) and ERAS group (119 cases) according to their decisions. Routine intervention and ERAS intervention were adopted in the 2 groups of patients during perioperative period, respectively. We comparatively analyzed postoperative visual analogue scale (VAS), the Oswestry disfunction index score (ODI), the application of opioids, postoperative complications, average length of postoperation stay, readmission rates during 1 month after surgery, satisfaction degree for the treatment, pain scores and dysfunction at follow up. Results The ERAS group patients had milder pain than the control group during 3 days after surgery, at discharge and 1 month after surgery (P<0.05). As compared with control group, the incidence of nausea and vomiting was significantly reduced (P<0.05), and opioids consumption was significantly decreased in 1st day and 2nd day after surgery in ERAS group (all P<0.05). In addition, the length of postoperation stay in ERAS group (4.9 days) was shorter than that in control group (6.2 days) (P<0.05). However, the readmission rate showed no statistically significant difference between the two groups (P=0.339). Average follow-up time was (13.4±0.9) months. There were no statistical differences in VAS (P=0.368) and ODI scores (P=0.251) between the two groups during the follow-up period. Conclusion ERAS can reduce the length of hospital stay, alleviate postoperative pain, and decrease the incidence of postoperative complications and the consumption of opioids in patients subject to lumbar fusion surgery without a concomitant increase in readmission rate. As a result, ERAS is worthy of clinical promotion in spine surgery.
What problem does this paper attempt to address?